Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,324
Closed -$453K 703
2024
Q3
$453K Sell
4,324
-1,470
-25% -$172K 0.03% 468
2024
Q2
$824K Buy
5,794
+493
+9% +$56.8K 0.05% 309
2024
Q1
$591K Buy
5,301
+259
+5% +$30.9K 0.04% 383
2023
Q4
$654K Buy
5,042
+13
+0.3% +$1.79K 0.05% 323
2023
Q3
$820K Buy
5,029
+274
+6% +$48.2K 0.07% 251
2023
Q2
$872K Sell
4,755
-53
-1% -$7.63K 0.07% 233
2023
Q1
$641K Sell
4,808
-594
-11% -$69.8K 0.06% 280
2022
Q4
$429K Sell
5,402
-239
-4% -$16.8K 0.04% 352
2022
Q3
$342K Buy
5,641
+235
+4% +$15.2K 0.04% 379
2022
Q2
$296K Sell
5,406
-671
-11% -$38.9K 0.03% 437
2022
Q1
$459K Buy
+6,077
New +$415K 0.04% 382

Other funds holding ACLS

Pitcairn's ACLS Position: Q4 2024 in Review

Pitcairn sold out of Axcelis (ACLS) in Q4 2024, closing a stake of 4,324 shares — an estimated $453K sold.

Pitcairn first reported a position in ACLS in Q1 2022 and held it in 11 quarters. The position peaked at $872K in Q2 2023. 324 funds tracked by Wall St. Rank hold ACLS as of Q4 2024.

  • Pitcairn reported no remaining Axcelis position as of Q4 2024 after selling out during the quarter.
  • Pitcairn sold 4,324 Axcelis shares in Q4 2024, an estimated $453K.
  • Pitcairn first reported a position in Axcelis in Q1 2022 and held it in 11 quarters.
  • Pitcairn's Axcelis position peaked at $872K in Q2 2023.
  • 324 funds tracked by Wall St. Rank held Axcelis as of Q4 2024.

Based on Pitcairn's 13F filing for Q4 2024, filed 12 Feb 2025.